Newsletter : Pompe Disease Newsletter



An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen in muscle and nerve cells throughout the body. Also called Glycogen Storage disease type II, Pompe disease affects around 5,000 to 10,000 people worldwide, with an equal preponderance in Males and females. DelveInsight's newsletter series brings to light an overview of Pompe disease, underlying cause, Etiology, Symptoms, Market and Epidemiology. Top companies involved : Tetra Therapeutics, , , Confluence Pharmaceuticals, and Neuren Pharmaceuticals. Have a Copy our Newsletter : https://www.delveinsight.com/whitepaper-newsletter/pompe-disease

Comments

Post a Comment

Popular posts from this blog

Hemodynamic Monitoring Systems Market

DelveInsight’s “ Hemodynamic Monitoring Systems Market  Insights, Competitive Landscape and Market Forecast-2026 ” report delivers an in-depth understanding of the Hemodynamic Monitoring Systems, historical and forecasted epidemiology as well as the Hemodynamic Monitoring Systems market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Recent developmental activities in  Hemodynamic Monitoring Systems market According to DelveInsight, the Hemodynamic Monitoring Systems market will increase at a CAGR of 6.29 percent during the forecasted period from 2021 to 2026, to reach USD 924 million by 2026.   In October 2020, Getinge launched NICCI – the latest innovation in Advanced Hemodynamic Monitoring. NICCI was Getinge’s latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients...
Read more

Chronic Neuropathic Pain Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Algiax Pharmaceuticals, Centrexion Therapeutics, Kineta and Others.

Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7–10% of the general population. DelveInsight's " Chronic Neuropathic Pain Market Insights, Epidemiology, and Market Forecast-2030"  report delivers an in-depth understanding of the Chronic Neuropathic Pain, historical and forecasted epidemiology as well as the Chronic Neuropathic Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some facts of Chronic Neuropathic Pain Market : ·          Chronic Neuropathic Pain is more frequent in women (8% vs. 5.7% in men) and in patients >50 years of age (8.9% vs. 5.6% in those <49 years of age), and most commonly affects the lower back and lower limbs, neck and upper limbs. ·          According to an article by Melillo (2020), publis...
Read more

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

DelveInsight's " Cervical Intraepithelial Neoplasia Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of Cervical Intraepithelial Neoplasia, historical and forecasted epidemiology as well as the Cervical Intraepithelial Neoplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cervical Intraepithelial Neoplasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cervical Intraepithelial Neoplasia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cervical Intraepithelial Neoplasia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cervical Intraepithelial Neoplasia market. Request for a Free Sample Report: Cervic...
Read more